...climbing since Oct. 15, when it jumped 13% from $18.24 on early data hinting that REL-1017...
...rather than weeks, but its use is restricted to the in-patient setting. Like Spravato and REL-1017...

...Relmada more than doubled its share price Tuesday after reporting Phase II data hinting that REL-1017...
...that can untangle the antidepressant and psychotomimetic effects of ketamine (see “Dissociating Ketamine” ). Though REL-1017...
...call Tuesday that REL-1017 would be administered in an outpatient setting in subsequent clinical trials. REL-1017...

...1 IL-10 - Interleukin-10 PDX1 (IPF1) - Pancreatic and duodenal homeobox 1 RELA (p65) - v-rel...
...FST) Frataxin (FXN) (FRDA) Heat shock transcription factor 1 (HSF1) Interleukin-10 (IL-10) Pancreatic and duodenal homeobox 1 (PDX1) (IPF1) Utrophin (UTRN) V-rel...

...CEACAM1 ( CD66a ) - Carcinoembryonic antigen-related cell adhesion molecule 1 c- REL (REL) - v-rel reticuloendotheliosis viral oncogene homolog avian...

...Relmada began a crossover, Canadian Phase I trial to compare single doses of oral REL-1028 vs...
...Therapeutics Inc. (OTCQB:RLMD), New York, N.Y. Product: Buprenorphine ( BuTab , BuTab ER ) ( REL-1028...

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Rheumatoid arthritis (RA) v-Rel reticuloendotheliosis...

...cases involved a fusion between chromosome 11 open reading frame 95 ( C11orf95 ) and v-rel...

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer V-rel reticuloendotheliosis viral oncogene...